Drug Name Description of Change Formulary Coverage Formulary Alternative(s)
|
|
- Thomas Hodge
- 5 years ago
- Views:
Transcription
1 NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the Presbyterian Centennial Care Formulary effective For the most recent list of drugs, information on asking for a prior authorization or exception, or other questions, please contact the Presbyterian Customer Service Center. You can reach them Monday through Saturday from 7:00 a.m. to 8:00 p.m. Phone: Phone: (505) Toll-free: Phone (Navajo/Diné): (505) Toll-free (Navajo/Diné): TTY: 711 Online: 01/15/2018 adapalene 0.1% gel (generic for Differin ) 01/15/2018 Advair HFA (fluticasone propionatesalmeterol) mcg/act, mcg/act, mcg/act metered dose inhalers Drug Name Description of Formulary Coverage Formulary Alternative(s) Removed from the formulary NF Differin OTC (adapalene 0.1%) PA required for patients 40 years of age. Removed from the formulary NF Asmanex HFA (mometason furoate) 100 mcg/act or 200 mcg/act metered dose inhaler - Formulary Flovent Diskus(fluticasone propionate) 50 mcg/inhalation, 100 mcg/inhalation, or 250 mcg/inhalation dry powder inhaler Formulary MPC Page 1 of 10 Centennial Care #2704
2 01/15/2018 Aliqopa (copanlisib HCL for IV solution) 60 mg vial ` 01/15/2018 Aristada (aripiprazole lauroxil) extended release suspension for intramuscular injection 441 mg, 662 mg, 882 mg, and 1064 mg 01/15/2018 atenolol/chlorthalidone (generic for Tenoretic ) 50/25 mg and 100/25 mg tablets 01/15/2018 Austedo (deutetrabenazine) 6 mg, 9 mg, 12 mg tablets Drug Name Description of Formulary Coverage Formulary Alternative(s) Formulary addition MB, PA PA requirement removed SP Formulary addition Formulary Formulary alternatives for Advair HFA continued Flovent HFA (fluticasone propionate) 44 mcg/act, 110 mcg/act, or 220 mcg/act metered dose inhaler fluticasone-salmeterol dry powder inhaler (generic for AirDuo Respiclick ) mcg/act, mcg/act, or mcg/act- ST Dulera (mometasone furoate-formoterol fumarate) mcg/act or mcg/act metered dose in haler ST Symbicort (budesonide-formoterol fumarate) mcg/act or mcg/act metered dose inhaler - ST MPC Page 2 of 10 Centennial Care #2704
3 Drug Name Description of Formulary Coverage Formulary Alternative(s) 01/15/2018 Benlysta (belimumab) for injection for, SP subcutaneous use 200 mg/ml single-dose prefilled autoinjector and single-dose prefilled syringe 01/15/2018 Besponsa (inotuzumab ozogamicin) Formulary addition MB, PA injection for IV infusion, 0.9 mg singledose vial 01/15/2018 Differin OTC (adapalene) Formulary addition PA required for patients 40 years of age 0.1% gel 01/15/2018 fenofibrate (generic for Tricor ) Formulary addition Formulary 48 mg and 145 mg tablets 01/15/2018 guanfacine ER tablets (generic for Formulary addition QL Intuniv ) 1 mg, 2 mg, 3 mg, 4 mg 01/15/2018 Kisqali Femara Co-Pack (ribociclib; letrozole) 200/2.5 mg tablets 01/15/2018 Lynparza (olaparib) 100 mg and 150 mg tablets 01/15/2018 memantine (generic for Namenda ) ST requirement removed QL 5 mg and 10 mg tablets 01/15/2018 Restasis MultiDose (cyclosporine ophthalmic emulsion) 0.05% 5.5 ml multidose bottle 01/15/2018 tetrabenazine (generic for Xenazine ) 12.5 mg and 25 mg tablets, SP. MPC Page 3 of 10 Centennial Care #2704
4 Drug Name Description of Formulary Coverage Formulary Alternative(s) 03/01/2018 Alecensa (alectinib) 150 mg capsules 03/01/2018 alfuzosin extended release (generic for Formulary addition QL Uroxatral) 10 mg tablets 03/01/2018 armodafinil (generic for Nuvigil) 150 mg tablets removed from formulary PA, QL 50 mg, 200 mg, and 250 mg tablets 03/01/2018 azelastine (generic for Astelin) Step therapy requirement removed Formulary 137 mcg/actuation (0.1%) nasal spray 03/01/2018 Calquence (acalabrutinib) 100 mg capsules 03/01/2018 diclofenac 1% topical gel (generic for Formulary addition QL Voltaren gel) 03/01/2018 Fiasp (insulin aspart injection) Formulary addition QL 100 units/ml, 10 ml multi-dose vial or 3 ml FlexTouch pen 03/01/2018 glatiramer acetate 40 mg/ml (generic for Copaxone 40 mg/ml) Formulary addition ST, QL, SP Glatopa 20 mg/ml (glatiramer acetate) QL, SP 03/01/2018 Heplisav-B [Hepatitis B Vaccine Formulary addition AL, QL (Recombinant), Adjuvanted] Solution for intramuscular injection 03/01/2018 Juluca (dolutegravir and rilpivirine) Formulary addition QL mg tablets 03/01/2018 KedRab Rabies Immune Globulin (Human) Solution for imtramuscular injection Formulary addition MB MPC Page 4 of 10 Centennial Care #2704
5 Drug Name Description of Formulary Coverage Formulary Alternative(s) 03/01/2018 Ocrevus (ocrelizumab) Specialty Pharmacy mandated MB, PA, SP 30 mg/ml intravenous solution 03/01/2018 QVAR RediHaler (beclomethasone dipropionate HFA) inhalation aerosol 40 mcg /actuation and 80 mcg/actuation 03/01/2018 rosuvastatin (generic for Crestor) 5 mg, 10 mg, 20 mg, 40 mg tablets 03/01/2018 Shingrix (zoster vaccine recombinant, adjuvanted) 03/01/2018 Vyxeos (daunorubicin and cytarabine) 44 mg/100 mg for injection 03/01/2018 Xeljanz XR (tofacitinib) 11 mg extended-release tablets Formulary addition ST Asmanex HFA (mometason furoate) 100 mcg/act or 200 mcg/act metered dose inhaler Flovent Diskus(fluticasone propionate) 50 mcg/inhalation, 100 mcg/inhalation, or 250 mcg/inhalation dry powder inhaler Flovent HFA (fluticasone propionate) 44 mcg/act, 110 mcg/act, or 220 mcg/act metered dose inhaler Formulary addition QL Formulary addition QL, AL Formulary addition MB, SP leflunomide tablets methotrexate tablets hydroxychloroquine tablets sulfasalazine tablets 03/01/2018 Zostavax (varicella virus vaccine) PA requirement added PA, QL, AL 06/01/2018 acitretin (generic for Soriatane ) Quantity limit changed PA, QL, SP 10 mg, 17.5 mg, and 25 mg capsules 06/01/2018 Afstyla [antihemophilic factor (recombinant), single chain] 250, 500, 1000, 1500, 2000, 2500, or 3000 IU Formulary addition MB, SP MPC Page 5 of 10 Centennial Care #2704
6 Drug Name Description of Formulary Coverage Formulary Alternative(s) 06/01/2018 alogliptin/pioglitazone (generic for Formulary addition ST, QL Oseni) mg, mg, mg, mg, mg, mg tablets 06/01/2018 alprazolam extended- release (generic Formulary addition ST, QL for Xanax XR) 0.5 mg, 1 mg, 2 mg, and 3 mg tablets 06/01/2018 Alunbrig (brigatinib) 90 mg and 180 mg tablets, 90 & 180 mg therapy pack 06/01/2018 aripiprazole (generic for Abilify ) PA requirement removed QL 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg tablets 06/01/2018 Biktarvy (bictegravir, emtricitabine, Formulary addition QL and tenofovir alafenamide) mg tablets 06/01/2018 Bosulif (bosutinib) Formulary addition (400 mg tablets) PA, QL, SP 100 mg, 400 mg, and 500 mg tablets PA requirements updated 06/01/2018 Cabometyx (cabozantinib), PA requirements updated PA, QL, SP 20 mg, 40 mg, and 20 mg tablets 06/01/2018 celecoxib (generic for Celebrex ) ST requirement removed QL 50 mg, 100 mg, 200 mg, and 400 mg capsules 06/01/2018 Cinvanti (aprepitant) Formulary addition MB, PA 130 mg/18 ml injectable emulsion 06/01/2018 Codeine containing medications listed on the formulary PA requirements added AL, PA* *Codeine containing products are not covered for patients < 12 years of age. A prior authorization will be required for patients aged 12 to 18 years. MPC Page 6 of 10 Centennial Care #2704
7 Drug Name Description of Formulary Coverage Formulary Alternative(s) 06/01/2018 clindamycin 1% topical gel and lotion QL added QL (generic for Cleocin T ) 06/01/2018 duloxetine (generic for Cymbalta ) QL updated QL 60 mg capsules 06/01/2018 Eloctate [antihemophilic factor (recombinant), Fc fusion protein] 250, 500, 750, 1000, 1500, 2000, 3000, 4000, 5000, and 6000 IU 06/01/2018 Enbrel Mini (etanercept) for injection 50 mg/ml single-dose prefilled cartridge for use with the AutoTouch reusable auto injector only 06/01/2018 enoxaparin (generic for Lovenox ) 30 mg/0.3 ml, 40 mg/0.4 ml, 60 mg/0.6 ml, 80 mg/0.8 ml, 100 mg/1 ml, 120 mg/0.8 ml, and 150 mg/1 ml prefilled syringes 06/01/2018 Erleada (apalutamide) 60 mg tablets 06/01/2018 Granix (tbo-filgrastim) 300 mcg/0.5 ml and 480 mcg/0.8 ml prefilled syringes 06/01/2018 Iclusig (ponatinib) 15 mg and 45 mg tablets 06/01/2018 Imbruvica (ibrutinib) 140 mg, 280 mg, 420 mg and 560 mg tablets packaged as a 4-week supply Removed from the formulary Non-formulary Nuwiq [antihemophilic factor (recombinant)], 250, 500, 1000, 2000, 2500, 3000 and 4000 IU - MB, SP, SP PA requirement added for quantities of enoxaparin that exceed plan quantity limits QL* *PA required for amounts that exceed plan quantity limits Removed from the formulary Non-formulary Zarxio (filgrastim-sndz), 300 mcg/0.5 ml and 480 mcg/0.8 ml prefilled syringes MB, PA PA requirements updated PA, QL, SP MPC Page 7 of 10 Centennial Care #2704
8 Drug Name Description of Formulary Coverage Formulary Alternative(s) 06/01/2018 Imfinzi (durvalumab) injection, for Formulary addition MB, PA intravenous use 120/2.4 ml and 500 mg/10 ml solution in a single-dose vial 06/01/2018 Isentress (raltegravir) QL updated QL 25 mg and 100 mg chewable tablets 06/01/2018 Kalydeco (ivacaftor),, SP 150 mg tablets; 50 mg and 75 mg oral granules 06/01/2018 Kovaltry [antihemophilic factor (recombinant)] Formulary addition MB, SP 250, 500, 1000, 2000, and 3000 IU 06/01/2018 Neupogen (filgrastim) injection 300 mcg/0.5 ml and 480 mcg/0.8 ml 06/01/2018 Nuvaring (ethinyl estradiol/ etonogestrel) mg vaginal ring 06/01/2018 Nuwiq [antihemophilic factor (recombinant)] 250, 500, 1000, 2000, 2500, 3000 and 4000 IU 06/01/2018 Orkambi (lumacaftor/ivacaftor) mg tablets 06/01/2018 Paxil (paroxetine) 10 mg/5 ml oral suspension 06/01/2018 Renflexis (infliximab-abda) 100 mg/vial Formulary removal Non-formulary Zarxio (filgrastim-sndz), 300 mcg/0.5 ml and 480 mcg/0.8 ml prefilled syringes MB, PA AL added ST, QL, AL (Maximum age of 55 years) Formulary addition MB, SP, SP PA requirement added PA, QL Formulary addition MB, PA, SP MPC Page 8 of 10 Centennial Care #2704
9 06/01/2018 Remicade (infliximab) 100 mg/vial 06/01/2018 Sprycel (dasatinib) 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg tablets 06/01/2018 Symdeko (tezacaftor/ivacaftor tablets; ivacaftor tablets) mg and 150 mg tablets 06/01/2018 Symfi Lo (efavirenz, lamivudine and tenofovir disoproxil fumarate) mg tablets 06/01/2018 Tasigna (nilotinib) 150 mg and 200 mg capsules 06/01/2018 Tramadol containing medications listed on the formulary 06/01/2018 Trogarzo (ibalizumab-uiyk) injection, for intravenous use 200 mg/1.33 ml in a single dose vial 06/01/2018 vancomycin (generic for Vancocin ), 125 mg capsules 06/01/2018 vancomycin (generic for Vancocin ), 250 mg capsules Drug Name Description of Formulary Coverage Formulary Alternative(s) PA requirements updated MB, PA, SP Renflexis* (infliximab-abda) MB, PA, SP *Renflexis will be the preferred infliximab product on the Centennial Care formulary. PA requirements updated PA, QL, SP, SP Formulary addition QL PA requirements updated PA, QL, SP PA requirements added AL, PA* *Tramadol containing products are not covered for patients < 12 years of age. A prior authorization will be required for patients aged 12 to 18 years. Formulary addition MB from PA to ST ST, QL metronidazole 500 mg tablets PA requirements updated PA, QL metronidazole 500 mg tablets MPC Page 9 of 10 Centennial Care #2704
10 Drug Name Description of Formulary Coverage Formulary Alternative(s) 06/01/2018 Verzenio (abemaciclib) 50 mg, 100 mg, 150 mg, and 200 mg tablets 06/01/2018 Victoza (liraglutide) PA requirements updated PA, QL 18 mg/3 ml pen injector 06/01/2018 Vimpat (lacosamide) PA requirements updated PA, QL 50 mg, 100 mg, 150 mg, 200 mg tablets and 10 mg/ml oral solution 06/01/2018 Xgeva (denosumab) injection, for PA requirements updated MB, PA, SP subcutaneous use 120 mg/1.7 ml (70 mg/ml) solution in a single-dose vial 06/01/2018 Xifaxan (rifaxamin) PA requirements updated PA, QL 200 mg and 550 mg tablets 06/01/2018 Xigduo XR (dapagliflozin/metformin) mg, mg, mg, mg, and mg tablets 06/01/2018 Xulane (norelgestromin/ethinyl estradiol) 150/35 mcg/day patch AL added ST, QL, AL (Maximum age of 55 years) Learn more about Presbyterian s Nondiscrimination Notice and Interpreter Services. MPC Page 10 of 10 Centennial Care #2704
Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the Presbyterian Commercial Large Group Plans (Non-Metal Plans) Formularies effective 2018. For the most recent list of drugs,
More informationPresbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the 2017 Presbyterian Individual and Family Metal Plan/Employer Group Metal Plan Formularies effective 2018. For the most recent
More informationPharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update SECOND QUARTER 2018 P&T Committee Decisions Effective June 1, 2018 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
More informationBlue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR
More informationNOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF CHANGES The following summary describes changes to the 2018 Presbyterian Senior Care (HMO)/(HMO-POS), Presbyterian MediCare PPO and formularies. The formulary may change at any time. You
More informationELEVATE. Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard)
ELEVATE Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard) P&T/Formulary Committee Actions 4Q 2017 (Effective January 1, 2018) Marketplace Standard
More informationMercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir
Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires
More information2018 CareOregon Advantage Part D Formulary Changes
2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD
More information2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This
More informationSeptember 2018 Pharmacy & Therapeutics Committee Decisions
UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to UCare (approved drug list). These changes are reviewed based
More informationPharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update THIRD QUARTER 2017 Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. P&T Committee Decisions Effective August 15, 2017 Dear Healthcare
More informationQuarterly pharmacy formulary change notice
Provider Bulletin October 2018 Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. The changes listed in the table
More informationSASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN 51st Edition
Saskatchewan Health Drug Plan and Extended Benefits Branch July, 2002 Bulletin #91 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN 51st Edition NEW LISTINGS NEW EXCEPTION DRUG STATUS AGENT
More informationHealth Partners Medicare Special 2018 Formulary Changes
Health Partners Medicare Special 2018 Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes available.
More informationQuarterly pharmacy formulary change notice
MEDICAID PROVIDER BULLETIN October 2018 The formulary changes listed in the table below were reviewed and approved at the second-quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
More informationMercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria
ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1 BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
More informationPeach State Health Plan routinely reviews the medications available on the Preferred Drug
Effective date: December 27, 2016 Peach State Health Plan Preferred Drug List (PDL) Updates Q4 2016 Peach State Health Plan routinely reviews the medications available on the Preferred Drug List (PDL).
More informationQuarterly pharmacy formulary change notice
Provider update Quarterly pharmacy formulary change notice Summary: The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018, Pharmacy and Therapeutics Committee
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More informationYou ll find the most up-to-date comprehensive version of our formulary on our website, Click on Drug Finder.
3/1/2018 Medicare Part D Formulary Change In an effort to cover the most needed, cost-effective prescriptions, the AlohaCare Advantage Plus (HMO SNP) Formulary is updated monthly. The following are drugs
More information2014 Step Therapy Criteria (List of Step Therapy Criteria)
Criteria Last Updated: November 1, 2014 2014 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP MEDICARE DUALCHOICE (HMO SNP) REQUIRES YOU TO FIRST TRY CERTAIN DRUGS TO TREAT
More information2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More information2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More informationPharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update FIRST QUARTER 2017 P&T Committee Decisions effective March 1, 2017 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
More information2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More informationJanuary 2018 Pharmacy & Therapeutics Committee Decisions
UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to the UCare formulary (approved drug list). These changes are reviewed
More informationQuarterly pharmacy formulary change notice
Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the
More informationAetna Better Health of Illinois Medicaid Formulary Updates
October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary
More informationMemorial Hermann Advantage HMO February 2019 Formulary Addendum
Memorial Hermann Advantage HMO February 2019 Formulary Addendum Changes may have occurred since the printing of your current Memorial Hermann Advantage HMO Formulary. Medications that may have been added
More informationThe following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016.
Q4 MHS PDL Changes Provider Notice The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016. Table 1: Summary of Medicaid PDL Additions
More informationDuring non-business hours, your call will be answered by our automated phone system. A representative will return your call the next business day.
MEICARE AVANTAGE BlueCross BlueShield of Western New York 2018 Formulary Update BlueCross BlueShield of Western New York has updated its formulary (drug list) since its original publication in January
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Provider update Summary: Effective August 1, 2018, the preferred formulary changes detailed in the table below will apply to District of Columbia Healthy Families
More informationReason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.
2017 Formulary Change Notice Please note these changes to your 2017 List of Covered Drugs Drug name (medication) Rubraca Aprepitant Onivyde Oseltamivir Restasis Xiidra Daptomycin Selzentry Linzess Butalb/APAP/caff
More informationQuarterly pharmacy formulary change
Medi-Cal Managed Care L. A. Care Major Risk Medical Insurance Program Provider Bulletin The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018 Pharmacy and
More informationTribute 2018 Formulary 2018 Quantity Limit Criteria
APREPITANT Aprepitant ORAL CAPSULE 125, 40, 80 Aprepitant Oral CAPSULE 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil ORAL TABLET 150, 200, 250, 50
More informationRelative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
More informationSuperior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Below is a list formulary changes for the benefit year 2018. This is not a complete list of drugs covered by the Part D plan. The
More informationKansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria
APREPITANT Kansas Health Advantage (HMO SNP) 2018 Formulary Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL
More informationStep Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG
More information2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January. This document
More informationJANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.
ANTI DIABETICS BYDUREON 2 MG SUBCUTANEOUS JANUVIA 25 MG TABLET EXTENDED RELEASE SUSPENSION JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET
More informationTABLE OF CONTENTS (Click on a link below to view the section.)
Follow the links below to access the complete formularies for Plans: Health Plan Acne Allergy Allergic Anaphylactic Reaction Allergic Conjunctivitis Allergic Rhinitis Asthma Atopic Dermatitis Behavioral
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Summary of change: The Pharmacy and Therapeutics Committee (P&T) reviewed and approved the formulary changes listed in the table below on March 29, 2016. What
More informationHealth Partners Medicare Special Formulary Updates
March 2018 Effective Date Brand Name Generic Name Type of Change 90 / 30 DAYS tenofovir disoproxil fumarate tenofovir disoproxil fumarate clobetasol propionate tenofovir disoproxil fumarate Previous Value
More informationOHIO MEDICAID PHARMACY COVERAGE
OHIO MEDICAID PHARMACY COVERAGE This information is intended for use by providers to help select the most appropriate cost-effective medication and formulation for their patients. Prescribers should utilize
More informationOregon Health Plan prescription benefit updates
Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save
More informationPPHP 2017 Formulary 2017 Step Therapy Criteria
ARISTADA Aristada Prefilled Syringe 1064 MG/3.9ML Intramuscular Aristada Prefilled Syringe 441 MG/1.6ML Intramuscular Aristada Prefilled Syringe 662 MG/2.4ML Intramuscular Aristada Prefilled Syringe 882
More informationAlameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions
Alameda Alliance for Health FORMULARY UPDATE Effective: April 21, 2017. Drugs notated with an * have an undetermined implementation date Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee
More informationAPREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE
APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50
More informationTribute 2018 Formulary 2018 Quantity Limit Criteria
APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50
More information2014 Quantity Limits (QL) Criteria
2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food
More informationAcyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria
Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time
More informationStep Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet
More informationPharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update THIRD QUARTER 2018 P&T Committee Decisions Effective September 1, 2018 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
More informationFIRST QUARTER 2018 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES
FIRST QUARTER 2018 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES Following is the First Quarter 2018 update to the Highmark Drug Formularies and pharmaceutical management procedures. The formularies
More informationThese programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.
FlexRx Standard Utilization Management (PA, QL,) Updates January 1, 2018 How to use this drug list This drug list includes updates to Utilization Management (UM) programs. UM may include a prior authorization
More informationAdded, Removed or Changed. Added, Removed or Changed
One mission: you s March 8, 2018 Blue Cross of Idaho reviews its formularies (covered drug lists) periodically to allow members access to new drugs and to provide safe, cost effective options for your
More informationStep Therapy Requirements. Effective: 11/01/2018
Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK
More informationTABLE OF CONTENTS (Click on a link below to view the section.)
Follow the links below to access the complete formularies for Plans: Buckeye Health Plan Acne Allergy Allergic Anaphylactic Reaction Allergic Conjunctivitis Allergic Rhinitis Asthma Atopic Dermatitis Behavioral
More informationUPMC for You Pharmacy and Therapeutics Committee Meeting April 7, 2014 meeting
UPMC for You Pharmacy and Therapeutics Committee Meeting April 7, 2014 meeting 1. Call to order: The meeting was called to order at 7:05 a.m. 2. Review of the minutes: The minutes of the January meeting
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Provider update Summary: The formulary changes listed in the table below were reviewed and approved at our second quarter 2018, Pharmacy and Therapeutics Committee
More informationStep Therapy Requirements. Effective: 05/01/2018
Step Therapy Requirements Effective: 05/01/2018 ANTIDEPRESSANTS TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG
More informationAlprazolam 0.25mg, 0.5mg, 1mg tablets
Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service
More informationSan Francisco Health Plan (SFHP)
San Francisco Health Plan (SFHP) The following changes to SFHP formulary and prior authorization criteria were reviewed and approved by the SFHP Pharmacy and Therapeutics (P&T) Committee on 04/18/2018.
More informationAetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates
Aetna Better Health Illinois Premier Plan November 2015 Formulary Updates desogestrel & ethinyl estradiol tab 0.15 mg-30 mcg RIVASTIGMINE DIS 13.3/24; QL (30 patches/30 days) RIVASTIGMINE DIS 4.6MG/24;
More informationMedicare Part D 2016 Formulary Changes Service To Senior and OC Preferred
Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior
More informationACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
More informationANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria
ANTIDEPRESSANTS Trintellix 10 mg tablet Trintellix 20 mg tablet Trintellix 5 mg tablet Viibryd 10 mg (7)-20 mg (23) tablets in a dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet
More informationPartners Notice of Change March 2017
New Added Products: Effective 3/1/2017 Drug Reason Tier Restrictions abacavir 600 mg-lamivudine 300 QL ADRENACLICK 0.15 MG/0.15 ML INJECTION,AUTO- INJECTOR ADRENACLICK 0.3 MG/0.3 ML INJECTION, AUTO- INJECTOR
More informationACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
More informationACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
More informationTABLE OF CONTENTS (Click on a link below to view the section.)
Follow the links below to access the complete formularies for Plans: Health Plan Acne Allergy Allergic Anaphylactic Reaction Allergic Conjunctivitis Allergic Rhinitis Asthma Atopic Dermatitis Behavioral
More informationInhaled Corticosteroids Drug Class Prior Authorization Protocol
Inhaled Corticosteroids Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review
More informationMedicare Part D 2016 Formulary Changes Service To Senior and OC Preferred
Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior
More informationVNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019
VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 04/01/2019 Updated 03/2019 AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED
More informationDiagnosis and Management of Asthma
Supporting Evidence: Diagnosis and Management of Asthma The subdivision of this section is: Appendix B Tables Copyright 2016 by 1 Eleventh Edition/December 2016 Appendix B Asthma Summary Tables Class:
More informationJanuary 2018 P & T Updates
January 2018 P & T Updates Commercial Triple Tier 4th Tier Applicable Traditional BEVYXXA 3 No 2 BOSULIF 3 2 * Indicates prior authorization (PA) or step (ST) Depending on your specific benefits and in
More informationStep Therapy Approval Criteria
Effective Date: 07/01/2015 This document contains for the following medications: 1. Ambien CR (zolpidem ER) 2. Chantix Continuing Month (varenicline) 3. Chantix Starting Month (varenicline) 4. Cymbalta
More informationWellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/21/2017.
More informationHealth Partners Medicare Prime 2019 Formulary Changes
Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes
More informationInhaled Corticosteroids Drug Class Prior Authorization Protocol
Inhaled Corticosteroids Drug Class Prior Authorization Protocol Line of Business: Medi-Cal P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review
More informationSan Francisco Health Plan (SFHP)
3T... 3T... harmacy and Therapeutics Committee Quarterly Formulary and rior Authorization Criteria Update San Francisco Health lan (SFH) Quarterly Formulary and rior Authorization Criteria Update The following
More informationTRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder
TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationMedicare Part D 2016 Formulary Changes Desert Preferred Choice
Medicare Part D 2016 Formulary s Desert Preferred Choice Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
More informationBlue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates April 2018 TRADE NAME (generic name) or generic name Brand/Generic Description of Change abacavir sulfate soln 20 mg/ml (base equiv) Generic
More information5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details
5-ASA DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum. 1 ANTIEMETICS
More informationAETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Summary: The formulary changes listed in the table below were reviewed and approved at our fourth-quarter Pharmacy and Therapeutics Committee meeting. Provider
More information5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release
Updated 11/1/17 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda
More informationPRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
More information